News

Updating My Outlook On Pfizer In Light Of The Recent Termination Of The Allergan Merger

4.06.16

See how corporate events such as upcoming the earnings announcement affect the outlook for PFE..

Read More

Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space

4.04.16

Article includes shapshot of corporate event data from Wall Street Horizon as it factors into the analysis of REGN...

Read More

My Thoughts On Gilead Sciences' Patent Loss

3.28.16

How will Gilead's forthcoming earnings release impact the share price? Check out Seeking Alpha's detailed analysis...

Read More

AbbVie Superior Dividend Makes It A Top Choice In The Health Care Sector

3.22.16

Critical corporate event data from Wall Street Horizon featured as author Alexander Poulos delves into the growth of ABBV...

Read More

Pfizer Is Poised For Long-Term Outperformance

3.21.16

See how Enchilada helped with PFE and AGN merger analysis...

Read More

What Zydelig's Failure Means For Gilead Investors

3.21.16

See how GILD's upcoming earnings announcement among other factors may affect the stock price...

Read More

Wall Street Horizon Partners with Informa’s BioMedTracker to provide FDA Drug Approval Dates and Pharmaceutical Intelligence to Investment Professionals

2.18.16

New partnership will give clients access to PDUFA dates, through Enchilada, its new online application...

Read More

WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders

2.18.16

The dataset will provide all relevant and potentially market-moving event dates around drug trials and approvals....

Read More